메뉴 건너뛰기




Volumn 104, Issue 1, 2011, Pages 1-3

Targeting IGF-1R: Throwing out the baby with the bathwater

Author keywords

[No Author keywords available]

Indexed keywords

ADVIGO 1018; CARBOPLATIN; CP 751; CP 871; ERLOTINIB; FIGITUMUMAB; GEFITINIB; MONOCLONAL ANTIBODY; PACLITAXEL; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

EID: 78650915213     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6606023     Document Type: Editorial
Times cited : (24)

References (18)
  • 1
    • 34249930520 scopus 로고    scopus 로고
    • Utility of free IGF-I measurements
    • Frystyk J (2007) Utility of free IGF-I measurements. Pituitary 10(2): 181-187
    • (2007) Pituitary , vol.10 , Issue.2 , pp. 181-187
    • Frystyk, J.1
  • 4
    • 33751076856 scopus 로고    scopus 로고
    • The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer
    • Han JY, Choi BG, Choi JY, Lee SY, Ju SY (2006) The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer. Lung Cancer 54(2): 227-234
    • (2006) Lung Cancer , vol.54 , Issue.2 , pp. 227-234
    • Han, J.Y.1    Choi, B.G.2    Choi, J.Y.3    Lee, S.Y.4    Ju, S.Y.5
  • 5
    • 77956227862 scopus 로고    scopus 로고
    • Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC)
    • Jassem J, Langer CJ, Karp DD, Mok T, Benner RJ, Green SJ, Park K, Novello S, Strausz J, Gualberto A (2010) Randomized, open label, phase III trial of figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC). J Clin Oncol (Meet Abstr) 28(Suppl 15): 7500
    • (2010) J Clin Oncol (Meet Abstr , Issue.28 SUPPL. 15 , pp. 7500
    • Jassem, J.1    Langer, C.J.2    Karp, D.D.3    Mok, T.4    Benner, R.J.5    Green, S.J.6    Park, K.7    Novello, S.8    Strausz, J.9    Gualberto, A.10
  • 12
    • 34249049000 scopus 로고    scopus 로고
    • Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib
    • Morgillo F, Kim WY, Kim ES, Ciardiello F, Hong WK, Lee HY (2007) Implication of the insulin-like growth factor-IR pathway in the resistance of non-small cell lung cancer cells to treatment with gefitinib. Clin Cancer Res 13(9): 2795-2803
    • (2007) Clin Cancer Res , vol.13 , Issue.9 , pp. 2795-2803
    • Morgillo, F.1    Kim, W.Y.2    Kim, E.S.3    Ciardiello, F.4    Hong, W.K.5    Lee, H.Y.6
  • 13
    • 77956571417 scopus 로고    scopus 로고
    • Targeting insulin-like growth factor signaling: Rational combination strategies
    • Olmos D, Basu B, de Bono JS (2010a) Targeting insulin-like growth factor signaling: rational combination strategies. Mol Cancer Ther 9(9): 2447-2449
    • (2010) Mol Cancer Ther , vol.9 , Issue.9 , pp. 2447-2449
    • Olmos, D.1    Basu, B.2    De Bono, J.S.3
  • 17
    • 77953973648 scopus 로고    scopus 로고
    • Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy
    • Ulanet DB, Ludwig DL, Kahn CR, Hanahan D (2010) Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy. Proc Natl Acad Sci USA 107(24): 10791-10798
    • (2010) Proc Natl Acad Sci USA , vol.107 , Issue.24 , pp. 10791-10798
    • Ulanet, D.B.1    Ludwig, D.L.2    Kahn, C.R.3    Hanahan, D.4
  • 18
    • 0033585421 scopus 로고    scopus 로고
    • Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis
    • Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 91(2): 151-156
    • (1999) J Natl Cancer Inst , vol.91 , Issue.2 , pp. 151-156
    • Yu, H.1    Spitz, M.R.2    Mistry, J.3    Gu, J.4    Hong, W.K.5    Wu, X.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.